Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes - PubMed (original) (raw)
Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes
D Rosenbaum et al. Am J Physiol. 1993 Feb.
Abstract
We have found that women with polycystic ovary syndrome (PCOS) have decreased sensitivity and responsiveness to insulin. The present study was performed to determine whether this impaired insulin responsiveness was associated with diminished GLUT-4 glucose transporter content in adipocytes. Insulin-stimulated glucose transport and GLUT-4 abundance were measured in abdominal adipocytes from obese (n = 9) and lean (n = 7) PCOS as well as obese (n = 8) and lean (n = 8) control women matched for age and weight. No woman had impaired glucose tolerance. The maximal insulin-stimulated increment in adipocyte glucose transport was independently decreased by obesity and by PCOS. As expected, GLUT-4 content in adipocyte membranes was decreased in obesity (by 40%, P < or = 0.01). GLUT-4 content was also significantly decreased in PCOS (by 36%, P < or = 0.01), independent of obesity. There was a highly significant correlation (R = 0.66, P < = 0.001) between GLUT-4 content and insulin-stimulated glucose transport in adipocytes from individual women across the study population. We conclude that the diminished adipocyte insulin responsiveness in PCOS is associated with decreased GLUT-4 abundance. This represents a newly recognized phenotypic feature of the insulin resistance of PCOS. Moreover, in human adipocytes, GLUT-4 abundance is highly correlated with insulin responsiveness.
Similar articles
- Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity.
Garvey WT, Maianu L, Huecksteadt TP, Birnbaum MJ, Molina JM, Ciaraldi TP. Garvey WT, et al. J Clin Invest. 1991 Mar;87(3):1072-81. doi: 10.1172/JCI115068. J Clin Invest. 1991. PMID: 1999488 Free PMC article. - Adipocyte expression of glucose transporter 1 and 4 in PCOS: Relationship to insulin-mediated and non-insulin-mediated whole-body glucose uptake.
Ezeh U, Chen IY, Chen YH, Azziz R. Ezeh U, et al. Clin Endocrinol (Oxf). 2019 Apr;90(4):542-552. doi: 10.1111/cen.13931. Epub 2019 Feb 14. Clin Endocrinol (Oxf). 2019. PMID: 30623452 Free PMC article. - Adipocyte Insulin Resistance in PCOS: Relationship With GLUT-4 Expression and Whole-Body Glucose Disposal and β-Cell Function.
Ezeh U, Chen IY, Chen YH, Azziz R. Ezeh U, et al. J Clin Endocrinol Metab. 2020 Jul 1;105(7):e2408-20. doi: 10.1210/clinem/dgaa235. J Clin Endocrinol Metab. 2020. PMID: 32382742 Free PMC article. - Adipose Tissue Dysfunction in Polycystic Ovary Syndrome.
Bril F, Ezeh U, Amiri M, Hatoum S, Pace L, Chen YH, Bertrand F, Gower B, Azziz R. Bril F, et al. J Clin Endocrinol Metab. 2023 Dec 21;109(1):10-24. doi: 10.1210/clinem/dgad356. J Clin Endocrinol Metab. 2023. PMID: 37329216 Free PMC article.
Cited by
- Adipose Insulin Resistance in Normal-Weight Women With Polycystic Ovary Syndrome.
Dumesic DA, Phan JD, Leung KL, Grogan TR, Ding X, Li X, Hoyos LR, Abbott DH, Chazenbalk GD. Dumesic DA, et al. J Clin Endocrinol Metab. 2019 Jun 1;104(6):2171-2183. doi: 10.1210/jc.2018-02086. J Clin Endocrinol Metab. 2019. PMID: 30649347 Free PMC article. - Polycystic ovary syndrome as a plausible evolutionary outcome of metabolic adaptation.
Dumesic DA, Padmanabhan V, Chazenbalk GD, Abbott DH. Dumesic DA, et al. Reprod Biol Endocrinol. 2022 Jan 10;20(1):12. doi: 10.1186/s12958-021-00878-y. Reprod Biol Endocrinol. 2022. PMID: 35012577 Free PMC article. Review. - Mitochondrial-Derived Peptides Are Down Regulated in Diabetes Subjects.
Ramanjaneya M, Bettahi I, Jerobin J, Chandra P, Abi Khalil C, Skarulis M, Atkin SL, Abou-Samra AB. Ramanjaneya M, et al. Front Endocrinol (Lausanne). 2019 May 31;10:331. doi: 10.3389/fendo.2019.00331. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31214116 Free PMC article. - Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome.
Fusco A, Bianchi A, Mancini A, Milardi D, Giampietro A, Cimino V, Porcelli T, Romualdi D, Guido M, Lanzone A, Pontecorvi A, De Marinis L. Fusco A, et al. J Endocrinol Invest. 2007 Dec;30(11):948-56. doi: 10.1007/BF03349243. J Endocrinol Invest. 2007. PMID: 18250617 Clinical Trial. - Impact of metabolic disorders on endometrial receptivity in patients with polycystic ovary syndrome.
Wang C, Wen YX, Mai QY. Wang C, et al. Exp Ther Med. 2022 Mar;23(3):221. doi: 10.3892/etm.2022.11145. Epub 2022 Jan 14. Exp Ther Med. 2022. PMID: 35222698 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials